In subsequent studies, phosphorylated tau proteins, including Thr231 (pT231), Ser396 (pS396), and Ser404 (pS404) were evaluated to determine whether the treatment with AM140 influenced the phosphorylation status of tau in AD‐like conditions. This evidence concerns the gene MAPT and Alzheimer disease.